Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


July 06, 2015 3:51 AM ET

Pharmaceuticals

Company Overview of Boehringer Ingelheim Limited

Company Overview

Boehringer Ingelheim Limited is engaged in the research, development, and manufacture of prescription medicines, over-the-counter, and animal healthcare products in the United Kingdom. It focuses on various medical conditions, such as respiratory, cardiology, virology, central nervous system, and cerebrovascular. The company offers prescription medicines for the treatment of chronic obstructive pulmonary disease, heart attack, secondary stroke prevention and treatment, high blood pressure, thromboembolic disease, HIV/AIDS, Parkinson's disease, arthritis, and pain relief in cancer. It offers consumer healthcare products in the areas of constipation, antispasmodics, stool softeners, vitamins a...

Ellesfield Avenue

Bracknell,  RG12 8YS

United Kingdom

Founded in 1955

Phone:

44 13 4442 4600

Fax:

44 13 4474 1444

Key Executives for Boehringer Ingelheim Limited

Managing Director
Finance & Administration Director
Senior Vice President of Global Biopharma Operations
Head of Established Markets
Compensation as of Fiscal Year 2015.

Boehringer Ingelheim Limited Key Developments

Boehringer Ingelheim Ltd. Wins GBP 230 Million Multiple Awardees Contract for Supplying Generic Pharmaceuticals

Boehringer Ingelheim Ltd. won a Wins GBP 230 million multiple awardees contract award from The Secretary of State for Health acting as part of the Crown through the Commercial Medicines Unit (part of the Department of Health) for the supply of generic pharmaceuticals (Contract Award Notice No.: 2015/S 100-182391).

Boehringer Ingelheim Ltd. Wins GBP 431.2 Million Multiple Awardees Contract

Boehringer Ingelheim Ltd. won a GBP 431.2 Million multiple awardees contract award from The Secretary of State for Health acting as part of the Crown through the Commercial Medicines Unit (part of the Department of Health) for the supply of proprietary pharmaceuticals (Contract Award Notice No.: 2015/S 073-128966).

Boehringer Ingelheim Limited Wins GBP 220.9 Million Contract for Supplying Proprietary Pharmaceuticals

Boehringer Ingelheim Limited won a GBP 220.9 million (excluding VAT) multiple awardees contract award from The Secretary of State for Health acting as part of the Crown through the Commercial Medicines Unit (part of the Department of Health) for the supply of proprietary pharmaceuticals (Contract Award Notice No.: 2015/S 057-099494). NHS Framework Agreement for the North of England Pharmacy Purchasing Group for the supply of Proprietary Pharmaceuticals - Tranche A. Period of framework agreement: 1.3.2015 to 28.2.2017 with an option to extend for up to a further 24 months.

Similar Private Companies By Industry

Company Name Region
Novartis UK Limited Europe
Napp Pharmaceutical Holdings Limited Europe
ORION Clinical Services Ltd. Europe
ReGen Therapeutics Limited Europe
Profile Pharma Limited Europe

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Boehringer Ingelheim Limited, please visit www.boehringer-ingelheim.co.uk. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.